Hypertonic Saline Solution to Prevent Acute Kidney Injury After Heart Transplantation
Recruiting
Phase 2
Interventional Study
Heart Transplantation
Acute Kidney Injury
Prior Safety Data
This treatment has already been tested in at least one earlier human trial.
Healthy Volunteers Welcome
You do not need to have the condition being studied to take part.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Trial phase
- Phase 2
- Study type
- Interventional
- Purpose
- Treatment
- Participants needed
- 74 (estimated)
- Sponsor
- Fernando Bacal · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The goal of this study is to evaluate if hypertonic saline solution can prevent or attenuate acute kidney injury after heart transplantation in the early postoperative phase.
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Hospitalized patients submitted to orthotopic heart transplantation (HT)
Exclusion Criteria:
* Requirement of renal replacement therapy at the time of HT
* Requirement of extracorporeal membrane oxygenation (ECMO) before or immediately after HT
* Severe peri-operative mechan…
Contacts
Núcleo Transplante Heart Institute / University of Sao Paulo
+55 1126615720
CONTACT